105.13 USD
+0.41
0.39%
At close Updated Dec 23, 3:53 PM EST
1 day
0.39%
5 days
7.08%
1 month
4.71%
3 months
31.48%
6 months
31.15%
Year to date
6.01%
1 year
5.8%
5 years
38.13%
10 years
107.97%
 

About: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Employees: 75,000

0
Funds holding %
of 7,526 funds
0
Analysts bullish %
of 7 analysts
0
Positive news %
of 69 articles
Price charts implemented using Lightweight Charts™